Table 2 Studies of salt restriction in patients with CKD

Nov 20, 2014

10 likes | 115 Views

Table 2 Studies of salt restriction in patients with CKD. Jain, N. & Reilly, R. F. (2014) Effects of dietary interventions on incidence and progression of CKD Nat. Rev. Nephrol. doi:10.1038/nrneph.2014.192.

Share Presentation

Embed Code

Link

progression
dietary interventions
salt restriction
2014 effects
doi 10
table 2 studies

jakeem-mooney

Download Presentation

Table 2 Studies of salt restriction in patients with CKD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Table 2 Studies of salt restriction in patients with CKD Jain, N. & Reilly, R. F. (2014) Effects of dietary interventions on incidence and progression of CKD Nat. Rev. Nephrol. doi:10.1038/nrneph.2014.192

Table Salt Electricity

Table Salt Electricity. Submitted by: Niya Williams Teacher: Mesiha Plummer Grade: Seven grade .

268 views • 13 slides

Section 2: Detection of CKD

Section 2: Detection of CKD. What Tests Are Available? . Direct GFR measurement Inulin clearance Radionuclides Iohexol clearance 3 hr CrCl with Cimetidine Prediction equations Cystatin C 24 hr urine CrCl Serum creatinine. Accurate. Inaccurate. Gold Standards.

267 views • 13 slides

CKD in individuals with CKD

CKD in individuals with CKD. Sylvia E. Rosas, MD, MSCE University of Pennsylvania Philadelphia VA Medical Center 3/19/2011. Objectives. Brief overview of pathophysiology of CKD. All-cause Mortality and CV Events According to Estimated GFR Go, et al. NEJM 2004. CKD is prevalent in CVD.

433 views • 26 slides

Table 2 Studies of rituximab treatment in MMN

Table 2 Studies of rituximab treatment in MMN. Vlam, L. et al. (2011) Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies Nat. Rev. Neurol. doi:10.1038/nrneurol.2011.175.

148 views • 1 slides

Table 1 Patients with late relapses described in the CORONA/SATURN and IMDC studies

Table 1 Patients with late relapses described in the CORONA/SATURN and IMDC studies. Ficarra, V. & Novara, G. (2013) Characterizing late recurrence of renal cell carcinoma Nat. Rev. Urol. doi:10.1038/nrurol.2013.239.

118 views • 1 slides

Burden, detection and evaluation of HCV in CKD patients

Burden, detection and evaluation of HCV in CKD patients. Dr Pankaj Hans Patna. India: Kidney disease burden. India is the world’s largest democracy with a population of around 1.13 billion and faces tremendous challenges to provide basic healthcare for its masses

495 views • 42 slides

Prevalence of CKD and ESRD in patients with heart failure, by self-reported race

Prevalence of CKD and ESRD in patients with heart failure, by self-reported race. Brar SS. AHA 59th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research; Sep 21-24, 2005; Washington, DC.

115 views • 1 slides

Predictors of disease progression in patients with CKD

Predictors of disease progression in patients with CKD. Boes E et al. J Am Soc Nephrol ; published online before print December 28, 2005. Time to progression in patients above and below the median cut point for apoA-IV levels.

168 views • 2 slides

Table 2 Studies investigating the symptoms of GUTB*

Table 2 Studies investigating the symptoms of GUTB*. Abbara, A. & Davidson, R. N. (2011) Etiology and management of genitourinary tuberculosis Nat. Rev. Urol. doi:10.1038/nrurol.2011.172.

108 views • 1 slides

Timely Referral and Co-Management of CKD Patients

Timely Referral and Co-Management of CKD Patients. Christopher Keller, MD Director of Clinical Operations Boise Kidney and Hypertension Institute RPA 2011 Annual Meeting Friday, March 18, 2011. Disclosure of Conflict of Interest. Timely Referral and Co-Management of CKD Patients.

312 views • 14 slides

Table 2 Studies of VUR in patients with or without BBD since 2008

Table 2 Studies of VUR in patients with or without BBD since 2008. Elder, J. S. & Diaz, M. (2013) Vesicoureteral reflux—the role of bladder and bowel dysfunction Nat. Rev. Urol. doi:10.1038/nrurol.2013.221.

125 views • 1 slides

ESAs and Outcomes in CKD Patients

ESAs and Outcomes in CKD Patients. Philip Lui PharmD The 13th Annual Contemporary Therapeutic Issues in Cardiovascular Disease May 8, 2010. Anemia in CKD Patients.

350 views • 17 slides

Management of Hyperkalemia in CKD patients

Management of Hyperkalemia in CKD patients. Dr. Overview. Introduction Hyperkalemia in CKD Incidence Significance Causes Management Summary and conclusions. Introduction. CKD Common disease Affecting a growing number of population across globe

1.43k views • 49 slides

Table 1 Evidence of premature ageing in CKD

Table 1 Evidence of premature ageing in CKD. Kooman, J. P. et al. (2014) Chronic kidney disease and premature ageing Nat. Rev. Nephrol. doi:10.1038/nrneph.2014.185.

92 views • 1 slides

Protein Energy Wasting in CKD Patients

A study was conducted to assess the nutritional status of CKD patients visiting Dr. B. R. A. Memorial hospital and Pt. J. N. M. medical College Raipur c.g. .A total of 50 subject from both sexes having means age 49.61 15.28 years undergoing hem dialysis were enrolled for the study. Information regarding disease history and associates co morbidities were collected from patients files. nutritional status was assessed by anthropometric measurements using body mass index BMI .the biochemical results including kidney profile , serum electrolytes and hemoglobin were recorded from the patients file. Dietary data was obtained by using 24 hour dietary recall and food frequency questionnaire. the results indicated that age, familial predisposition, hypertension, diabetes and heart disease increased the risk for renal failure. Protein energy wasting PEW is common in patients with chronic kidney disease CKD . PEW is one of the strongest predictors of mortality in patients with CKD. The International Society of Renal Nutrition and Metabolism ISRNM expert panel has defined PEW as a, "state of decreased body stores of protein and energy fuels body protein and fat masses . The ISRNM panel has also proposed diagnostic criteria of PEW with four categories. Cachexia is a severe form of PEW. The proposed causes of PEW are multi factorial and include nutritional and non nutritional mechanisms. The literature indicates that PEW can be mitigated or corrected with an appropriate diet and enteral nutritional support that targets dietary protein intake. Dietary requirements and enteral nutritional support must also be considered in patients with CKD and diabetes mellitus and in children with CKD, in addition to dialysis patients. Features of ideal dietary supplement have also been discussed. Dietary interventions such as enteral feeding with high protein meals or supplements might improve the nutritional status and outcomes in dialysis patients. Neha Jain "Protein Energy Wasting in CKD Patients" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-4 , June 2018, URL: https://www.ijtsrd.com/papers/ijtsrd14603.pdf Paper URL: http://www.ijtsrd.com/other-scientific-research-area/other/14603/protein-energy-wasting-in-ckd-patients/neha-jain

46 views • 4 slides

Protein Energy Malnutrition in CKD Patients

Elevated protein catabolism and protein malnutrition are common in patients with chronic kidney disease CKD and end stage renal disease ESRD . The underlying etiology includes, but is not limited to, metabolic acidosis intestinal dysbiosis systemic inflammation with activation of complements, endothelin 1 and renin angiotensin aldosterone RAAS axis anabolic hormone resistance energy expenditure elevation and uremic toxin accumulation. All of these derangements can further worsen kidney function, leading to poor patient outcomes. Many of these CKD related derangements can be prevented and substantially reversed, representing an area of great potential to improve CKD and ESRD care. This review integrates known information and recent advances in the area of protein nutrition and malnutrition in CKD and ESRD. Management recommendations are summarized. Thorough understanding the pathogenesis and etiology of protein malnutrition in CKD and ESRD patients will undoubtedly facilitate the design and development of more effective strategies to optimize protein nutrition and improve outcomes Suraj Kumar Singh | Atul Verma | Hulsi Sahu "Protein Energy Malnutrition in CKD Patients" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-5 , August 2018, URL: https://www.ijtsrd.com/papers/ijtsrd15704.pdf Paper URL: http://www.ijtsrd.com/other-scientific-research-area/other/15704/protein-energy-malnutrition-in-ckd-patients/suraj-kumar-singh

103 views • 4 slides

Electrolyte Imbalance in CKD Patients

The primary function of the kidney is to maintain fluid and electrolyte homeostasis. Each day the kidney must excrete 1500 ml of water and any excess ingested sodium, potassium, magnesium and phosphate. The kidney also plays a key role in calcium homeostasis. Of the total number of patients in intensive care 325 will develop acute renal failure and patients with chronic renal disease will frequently present for surgery. The treatments for renal dysfunction may themselves cause disturbance in fluid and electrolyte homeostasis, particularly the use of diuretics and renal replacement therapy. Loss of normal renal function may lead to major changes in fluid and sodium balance. Volume status assessment will be required in patients with renal dysfunction because they are at risk of both hypovolaemia and hypervolaemia. Loss of renal function will lead to retention of potassium and magnesium with serious systemic and cardiovascular consequences including cardio respiratory compromise and collapse and cardiac dysrhythmias. Hypocalcaemia will result from reduced renal calcitriol production and phosphate retention. The identification of fluid and electrolyte imbalances and the management of clinically significant changes are required when treating patients with renal dysfunction on an intensive care unit or who present for anaesthesia. Suraj Kumar Singh | Hulsi Sahu | Atul Verma "Electrolyte Imbalance in CKD Patients" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-2 | Issue-5 , August 2018, URL: https://www.ijtsrd.com/papers/ijtsrd15802.pdf Paper URL: http://www.ijtsrd.com/other-scientific-research-area/other/15802/electrolyte-imbalance-in-ckd-patients/suraj-kumar-singh

47 views • 4 slides

What should the Systolic BP treatment goal be in patients with CKD?

What should the Systolic BP treatment goal be in patients with CKD?. Age-Adjusted Rate of ESRD Due to Any Cause per 100,000 Person-Years, According to SBP and DBP in 332,544 Men Screened for MRFIT. N Engl J Med 1996;334:13-8.

206 views • 20 slides

Beneficial effects of sodium restriction on outcome of renoprotective therapy in CKD

Beneficial effects of sodium restriction on outcome of renoprotective therapy in CKD. Gerjan Navis UMCG Groningen The Netherlands. Saltintake around the world. Recommended. Sodium intake over time. Sodium restriction and ACEi in essential hypertension.

471 views • 46 slides

Section 2: Detection of CKD

Section 2: Detection of CKD. What Tests Are Available?. Direct GFR measurement Inulin clearance Radionuclides Iohexol clearance 3 hr CrCl with Cimetidine Prediction equations Cystatin C 24 hr urine CrCl Serum creatinine. Accurate. Inaccurate. Gold Standards. Inulin clearance

137 views • 13 slides

More Related